期刊文献+

乙型肝炎病毒cccDNA检测与血清学及病理诊断关系 被引量:3

Relationship of detection of cccDNA of hepatitis B virus and serum and pathology
下载PDF
导出
摘要 目的建立和应用聚合酶链反应法(PCR),检测慢性乙型肝炎患者肝组织中乙型肝炎病毒(HBV)共价闭合环状DNA(cccDNA),探讨慢性乙型肝炎肝组织HBV cccDNA与乙型肝炎的血清学及病理关系。方法分别采用PCR法检测慢性乙型肝炎患者肝组织HBV cccDNA,同时用免疫组化法检测肝细胞中HBcAg、Pres1;荧光定量PCR法检测慢性乙型肝炎患者血清HBV DNA载量;电发光化学方法检测慢性乙型肝炎患者乙型肝炎病毒标志物。分析肝组织HBV cccDNA与血清HBV DNA载量、HBeAg、HBeAb,以及肝细胞内HBcAg、Pres1的关系。结果①127例慢性乙型肝炎患者肝组织HBV cccDNA与血清HBV DNA载量呈正相关(P<0.01)。②127例慢性乙型肝炎患者肝组织HBV cccDNA阳性组与HBV cccDNA阴性组血清HBV DNA载量及肝细胞内HBcAg、Pres1无显著性差异(P>0.05)。③HBV cccDNA阳性组的HBeAg检出率明显高于HBV cccDNA阴性组,HBV cccDNA阴性组的HBeAb检出率明显高于HBV cccDNA阳性组。结论测定肝组织中HBV cccDNA,对于了解乙肝患者病情和传染性强弱以及评价肝脏炎症活动度有重要意义。 [ Objective ] To establish and polymerase chain reaction (PCR) testing in patients with chronic hepatitis B liver hepatitis B virus (HBV) eovalently closed circular DNA (eccDNA), chronic hepatitis B and liver HBV cceDNA Hpatitis B serology and the relationship between pathology. [Methods] PCR method used in patients with chronic hepatitis B liver HBV cccDNA, at the same time using immunohistochemistry detection of liver cells HBcAg, Presl, FQ-PCR detection of chronic hepatitis B patients with serum HBV DNA load, the electric light-emitting chemical Detected in patients with chronic hepatitis B virus, hepatitis B markers. Analysis of liver serum HBV cceDNA and HBV DNA load, HBeAg, HBeAb, liver cells HBeAg, Presl. [Results] 127 cases of patients with chronic hepatitis B and liver HBV eceDNA serum HBV DNA load was positively correlated (P 〈0.01). 127 patients with chronic hepatitis B patients with HBV cceDNA in liver tissue HBV cecDNA positive group and negative serum HBV DNA load cells and liver HBcAg, Presl no significant difference (P 〉0.05). HBV cccDNA group of HBeAg-positive rate was significantly higher than HBV eccDNA negative group, HBV cccDNA positive.HBeAb the negative group was significantly higher than the rate of HBV cccDNA positive. [ Conclusion] Measurement of liver HBV cccDNA, for understanding hepatitis B patients with infectious disease and inflammation of the liver as well as evaluating the strength of activity is of great significance.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第22期3435-3437,3440,共4页 China Journal of Modern Medicine
关键词 乙型肝炎病毒 CCCDNA 聚合酶链反应 慢性乙型肝炎 hepatitis B virus cccDNA polymerase chain reaction chronic hepatitis B
  • 相关文献

参考文献4

二级参考文献63

  • 1Lin Zhuang Jing You Bao Zhang Tang Su Ying Ding Kui Hua Yan Dan Peng Yan Mei Zhang Lu Zhang ~1Department of Hepatology,Kunming Third Municipal Peoples Hospital,Kunming 650041,Yunnan Province,China ~2Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China.Preliminary results of Thymosin-a1 versus interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B[J].World Journal of Gastroenterology,2001,7(3):407-410. 被引量:22
  • 2Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 3[1]Mast EE,Alter MJ,Margolis HS.Strategies to prevent and control hepatitis B and C virus infections:a global perspective.Vaccine 1999; 17:1730-1733
  • 4[2]Seeger C,Mason WS.Hepatitis B virus biology.Microbiol Mol Biol Rev 2000; 64:51-68
  • 5[3]Shafritz DA,Lieberman HM.The molecular biology of hepatitis B virus.Annu Rev Med 1984; 35:219-232
  • 6[4]Hoofnagle JH,di Bisceglie AM.The treatment of chronic viral hepatitis.N Engl J Med 1997; 336:347-356
  • 7[5]Chan HL,Leung NW,Hui AY,Wong VW,Liew CT,Chim AM,Chan FK,Hung LC,Lee YT,Tam JS,Lam CW,Sung JJ.A randomized,controlled trial of combination therapy for chronic hepatitis B:comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.Ann Intern Med 2005;142:240-250
  • 8[6]Mutimer D,Naoumov N,Honkoop P,Marinos G,Ahmed M,de Man R,McPhillips P,Johnson M,Williams R,Elias E,Schalm S.Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection:results of a pilot study.J Hepatol 1998; 28:923-929
  • 9[7]Dienstag JL,Schiff ER,Wright TL,Perrillo RP,Hann HW,Goodman Z,Crowther L,Condreay LD,Woessner M,Rubin M,Brown NA.Lamivudine as initial treatment for chronic hepatitis B in the United States.N Engl J Med 1999; 341:1256-1263
  • 10[8]Schiff ER,Karayalcin S,Grimm I,Perillo RM,Dienstag J,Husa P,Schalm S,Crowther L,Sullivan M,Woessner M,McPhillips P,Brown N,and the international Lamivudine Investigator Group.A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy (abstr).Hepatology 1998; 28:388A

共引文献14105

同被引文献27

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部